Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report

Figure 1

Mean ± SD of serum (a) activin-A, (b) activin-B, (c) follistatin, (d) AFRI, (e) BFRI, and (f) ASFRI in the different study groups (^a𝑃=0.05 compared to NC, ^b𝑃<0.05 compared to PC, ^c𝑃<0.05 compared to 4 W, ^d𝑃<0.05 compared to 12 W, ^e𝑃<0.05 compared to 24 W, and ^f𝑃<0.05 compared to R).

(a)

(b)

(c)

(d)

(e)

(f)